Autopsy report · NCT02966002
Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients
Cause of deathSlow enrollment
“This study was terminated due to inability to recruit sufficient patients.”
Life of this trial
- Registered 7 months after it had already started.
- Ran for about 1 year 1 month before it stopped.
- 9 participants enrolled.
- Results were posted on the registry 1 year after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- University of Michigan
- Sponsor type
- University, hospital or other
- Conditions
- Fontan Procedure
- Interventions
- Aspirin
- Participants
- 9
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF
“The study was terminated due to difficulty in recruiting patients.” - Long-term Extension Study of MCI-196
“This study has been terminated because of insufficient patient recruitment.” - Ultrasound-guided Hydrosalpinx Aspiration During Egg Collection
“The study was terminated because it is very difficult to recruit more patients.” - Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.
“The study was terminated early due to the inability to recruit the planned number of patients” - Alvimopan Use in Polytraumatized Patients
“This study was terminated due to failure to enroll, a low volume of patients met criteria.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.